The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...
Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...
Prescriptions Rising for a New Non-Opioid Analgesic, but Clinicians Are Still Learning Where It Fits
Prescriptions for the new non-opioid pain medication suzetrigine more than doubled between April and August 2025, according to analysis from Epic Research. The increase indicates a growing interest in ...
The Food and Drug Administration has approved a new pain medication that could take the place of opioids for those experiencing moderate to severe acute pain. The drug is Journavx, or the generic name ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat ...
The Food and Drug Administration approved Vertex Pharmaceuticals' non-opioid painkiller pill, a new alternative for pain relief that comes without the risk of addiction. It's a milestone after a long ...
Investigators used the SEER-Medicare claims linked database to explore the persistence of racial-ethnic disparities in pain treatment among survivors of cancer.
CHATHAM, NEW JERSEY / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp.
A combination of acetaminophen (Tylenol) and ibuprofen (Advil, Motrin) controls pain after wisdom tooth removal better than opioids, according to a Rutgers Health study that could change how dentists ...
How does your doctor actually prescribe opioid medication? Why is it hard to get a refill? What are the best solutions to help patients with pain?
(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results